Faculty, Staff and Student Publications
Open-access journal articles from UTHealth GSBS faculty, staff and students.
Submissions from 2025
Improved Overall Survival in an Anti-Pd-L1 Treated Cohort of Newly Diagnosed Glioblastoma Patients Is Associated With Distinct Immune, Mutation, and Gut Microbiome Features: A Single Arm Prospective Phase I/II Trial, Shiao-Pei Weathers, Xiqi Li, Haifeng Zhu, et al.
CAR-Macrophage Cell Therapy: A New Era of Hope for Pancreatic Cancer, Daoyan Wei, Liang Wang, Yi Liu, et al.
Concurrent Bone Marrow Acute Undifferentiated Leukemia and Mediastinal T‐Lymphoblastic Lymphoma With Identical SET::NUP214 Fusion and PHF6 and EZH2 Mutations, Qing Wei, Fatima Z Jelloul, Sa A Wang, et al.
Cryptic KMT2A::AFDN Fusion Due to AFDN Insertion into KMT2A in a Patient with Acute Monoblastic Leukemia, Qing Wei, Gokce A Toruner, Beenu Thakral, et al.
Cryptic KMT2A::AFDN Fusion Due to AFDN Insertion into KMT2A in a Patient with Acute Monoblastic Leukemia, Qing Wei, Gokce A Toruner, Beenu Thakral, et al.
Dose Planning and Radiation Optimization for Thoracic Conventional, Twice Daily, and Stereotactic Radiation Therapy: A Delphi Consensus From a National Survey of Practitioners, Julius Weng, Jeff Ryckman, Matthew S Katz, et al.
Autologous T cell therapy for PRAME, Martin Wermke, Dejka M Araujo, Manik Chatterjee, et al.
Tumoral and Circulating Genomic Landscape Inform Survival Differences in Colorectal Carcinomatosis, Michael G White, Reed I Ayabe, Mohammad A Zeineddine, et al.
The Landscape of ctDNA in Appendiceal Adenocarcinoma, Michael G White, Mohammad A Zeineddine, Eleanor A Fallon, et al.
Zongertinib (BI 1810631), an Irreversible HER2 TKI, Spares EGFR Signaling and Improves Therapeutic Response in Preclinical Models and Patients with HER2-Driven Cancers, Birgit Wilding, Lydia Woelflingseder, Anke Baum, et al.
Reduced Venetoclax Exposure to 7 Days vs Standard Exposure With Hypomethylating Agents in Newly Diagnosed Aml Patients, Christophe Willekens, Alexandre Bazinet, Samy Chraibi, et al.
Nature-Inspired Metaheuristics for Optimizing Dose-Finding and Computationally Challenging Clinical Trial Designs, Weng Kee Wong, Yevgen Ryeznik, Oleksandr Sverdlov, et al.
A Multimodal Approach To Assess a Liposomal Carrier’s Biodistribution, Stability, and Clearance, Cayla A Wood, Claire E Jones, Ananthakrishnan Soundaram Jeevarathinam, et al.
Home-Based Transcranial Direct Current Stimulation for Major Depressive Disorder: 6-Month Follow-Up From Randomised Sham-Controlled Trial and Open-Label Treatment Phases, Rachel D Woodham, Sudhakar Selvaraj, Nahed Lajmi, et al.
Deescalation Perils in Inflammatory Breast Cancer, Wendy A Woodward
Geographic Disparities in Access to Outpatient Stroke Rehabilitation in Texas, Joseph Wozny, Melissa Howard, Susan Doherty, et al.
A Critical Assessment of Artificial Intelligence in Magnetic Resonance Imaging of Cancer, Chengyue Wu, Meryem Abbad Andaloussi, David A Hormuth, et al.
MRI-Based Digital Twins to Improve Treatment Response of Breast Cancer by Optimizing Neoadjuvant Chemotherapy Regimens, Chengyue Wu, Ernesto A B F Lima, Casey E Stowers, et al.
ORP2 Regulates Free Cholesterol Accumulation in Hepatocytes During MASH, Jin Wu, Yudi Zhao, Liwen Qiu, et al.
The Heterogeneity of 13q Deletions in Chronic Lymphocytic Leukemia: Diagnostic Challenges and Clinical Implications, Changqing Xia, Guang Liu, Jinglan Liu, et al.
Evolution of Esophageal Adenocarcinoma From Precursor Lesion Stem Cells, Wa Xian, Shan Wang, Jingzhong Xie, et al.
Receptor Tyrosine Kinase Fusion-Mediated Resistance to EGFR TKI in EGFR-Mutant NSCLC: A Multi-Center Analysis and Literature Review, Yang Xia, Kaiwen Wang, Jing Zhao, et al.
A New Cure Model Accounting for Longitudinal Data and Flexible Patterns of Hazard Ratios Over Time, Can Xie, Xuelin Huang, Ruosha Li, et al.
SWI/SNF Complex-Mediated ZNF410 Cooperative Binding Maintains Chromatin Accessibility and Enhancer Activity, Siyuan Xu, Chuxuan Peng, Ren Ren, et al.
Deep Learning Models Based on Pretreatment MRI and Clinicopathological Data to Predict Responses to Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer, Zhan Xu, Zijian Zhou, Jong Bum Son, et al.